Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Dow
Mallinckrodt
Harvard Business School
Boehringer Ingelheim

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Cipla Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for Cipla

Drugs and US Patents for Cipla

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla PREGABALIN pregabalin CAPSULE;ORAL 212280-006 Jan 10, 2020 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Cipla RANOLAZINE ranolazine TABLET, EXTENDED RELEASE;ORAL 211291-001 May 28, 2019 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Cipla LAMIVUDINE lamivudine TABLET;ORAL 077221-002 Mar 3, 2017 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Cipla CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 208915-002 Mar 8, 2018 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Cipla Ltd DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 077518-002 May 31, 2011 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Cipla GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 078759-001 Jul 25, 2011 AP RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Cipla PREGABALIN pregabalin CAPSULE;ORAL 212280-002 Jan 10, 2020 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Cipla Drugs

Country Patent Number Estimated Expiration
Japan 2011219498 ⤷  Sign up for a Free Trial
Croatia P20170154 ⤷  Sign up for a Free Trial
Slovenia 2217610 ⤷  Sign up for a Free Trial
Israel 205880 ⤷  Sign up for a Free Trial
Lithuania 2217610 ⤷  Sign up for a Free Trial
Brazil PI0819319 ⤷  Sign up for a Free Trial
China 103360440 ⤷  Sign up for a Free Trial
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for Cipla Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0122707 96C0030 Belgium ⤷  Sign up for a Free Trial PRODUCT NAME: CHLORHYDRATE DE GEMCITABINE EQUIVALENT EN GEMCITABINE; NAT. REGISTRATION NO/DATE: 58 IS 88 F 12 19960606; FIRST REGISTRATION: NL RVG 17854 19950327
1131065 92488 Luxembourg ⤷  Sign up for a Free Trial PRODUCT NAME: DIMETHYL FUMARATE. FIRST REGISTRATION: 20140130
2203431 CR 2015 00014 Denmark ⤷  Sign up for a Free Trial PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
0915894 SPC/GB05/041 United Kingdom ⤷  Sign up for a Free Trial SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB05/041 GRANTED TO GILEAD SCIENCES, INC. IN RESPECT OF THE PRODUCT COMPOSITION CONTAINING BOTH TENOFOVIR DISOPROXIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, TAUTOMER OR SOLVATE THEREOF, TOGETHER WITH EMTRICITABINE , THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6233 DATED 05/11/2008 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 23/02/2020.
1912999 2014/058 Ireland ⤷  Sign up for a Free Trial PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516
1663240 223 5021-2015 Slovakia ⤷  Sign up for a Free Trial PRODUCT NAME: EMTRICITABIN/RILPIVIRINHYDROCHLORID/TENOFOVIRDIZOPROXILFUMARAT; REGISTRATION NO/DATE: EU/1/11/737/001 - EU/1/11/737/002 20111128
1663240 300851 Netherlands ⤷  Sign up for a Free Trial PRODUCT NAME: COMBINATIE VAN: - RILPIVIRINE OF EEN THERAPEUTISCH EQUIVALENTE VORM DAARVAN ZOALS BESCHERMD DOOR HET BASISOCTROOI, ZOALS EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN RILPIVIRINE, WAARONDER HET HYDROCHLORIDEZOUT VAN RILPIVIRINE; - EMTRICITABINE; EN - TENOFOVIRALAFENAMIDE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER TENOFOVIRALAFENAMIDEFUMARAAT; REGISTRATION NO/DATE: EU/1/16/1112 20160623
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Medtronic
Johnson and Johnson
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.